Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Juan Fernandez-Miranda

Neurological Surgery Stanford, CA Medical Doctor

NPI 1407059181 CMS profile 108412

300 Pasteur Dr, Stanford, CA 94305

Open in the dashboard

General payments

$73,928

81 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Juan Fernandez-Miranda of Stanford, CA is reported in the CMS Open Payments database as having received $73,928 across 81 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $26,220 35
2024 General $997 14
2023 General $9,969 16
2022 General $7,316 5
2021 General $22,307 5
2020 General $5,782 4
2019 General $1,338 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Juan Fernandez-Miranda
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Juan Fernandez-Miranda were reported at $26,220. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Juan Fernandez-Miranda Neurological Surgery median Middle half National median
2019 $1,338 $582 $138–$3,006 $163
2020 $5,782 $294 $76–$2,174 $114
2021 $22,307 $387 $105–$2,432 $132
2022 $7,316 $542 $139–$2,989 $149
2023 $9,969 $534 $145–$2,697 $160
2024 $997 $574 $155–$3,046 $164
2025 $26,220 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $27,895 46 payments
  2. Carl Zeiss Meditec USA, Inc. $21,859 1 payment
  3. Stryker Corporation $7,833 12 payments
  4. Mizuho America, Inc. $7,374 2 payments
  5. Integra LifeSciences Corporation $5,083 2 payments
  6. KLS-Martin L.P. $2,506 15 payments
  7. Medtronic USA, Inc. $1,200 1 payment
  8. Penumbra, Inc. $138 1 payment
  9. Davol Inc. $40 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $26,700 5 payments
  2. Long term medical supply or device loan $21,859 1 payment
  3. Consulting Fee $12,960 4 payments
  4. Charitable Contribution $7,374 2 payments
  5. Royalty or License $2,474 14 payments
  6. Food and Beverage $2,426 51 payments
  7. Travel and Lodging $135 4 payments
Products named General payments · program years 2019–2025
  1. MIDAS REX $24,937 40 payments
  2. KINEVO $21,859 1 payment
  3. DURAGEN $5,000 1 payment
  4. DURASEAL EXACT $5,000 1 payment
  5. CODMAN CERTAS $5,000 1 payment
  6. STRAIGHTSHOT $1,700 1 payment
  7. RHINOBUR $1,200 1 payment
  8. STEALTHSTATION S8 PLATFORM $1,037 3 payments
  9. Retractor $910 5 payments
  10. CORE $271 3 payments
  11. Other $1,184 15 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 31 billing codes

Paid by Medicare

$76,121

Medicare's payments for the services billed

Medicare patients

158

Average age 70

Services billed

264

87 women, 71 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 66%
Arthritis 37%
Diabetes 27%
Ischemic heart disease 22%
Osteoporosis 22%
Depression 19%
Cancer 16%
Heart failure 14%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

81 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record